During the past decade, Anthony Mills conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Anthony Mills" are "HIV Infections" (1 trials), "HIV-1 Infection" (1 trials), "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19" (1 trials) and "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol" (1 trials). Many other conditions were trialed in "Anthony Mills" in a lesser frequency.

Most popular intervention types in "Anthony Mills" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.COV2.S" (2 trials), "Placebo" (2 trials), "Cenicriviroc 100 mg" (1 trials), "Cenicriviroc 200 mg + Truvada" (1 trials) and "Efavirenz" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anthony Mills" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Anthony Mills". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Anthony Mills, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Anthony Mills, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".